glp-1 and eye disease Semaglutide Tied to Increased Risk of Serious GLP-1 Drug Linked to Cases

Direct supplementation risks disrupting the body's innate GH rhythm, potentially resulting in side effects like joint pain, muscle aches, or even more severe conditions like diabetes

Fortunately, GLP1 medications are now FDA-indicated for multiple indications beyond weight management and diabetes, including: Major cardiovascular event (heart attack and/or stroke) risk reduction in adults with cardiovascular disease and overweight or obesity Metabolic dysfunctionassociated steatohepatitis (MASH) Moderate to severe obstructive sleep apnea (OSA) in adults with obesity When one medication can address multiple conditions, it simplifies care and reduces polypharmacy

Immunologists disagree about whether it is an autoimmune disease

Using ordinary or distilled water , it is neither sterile nor preserved, a risk of contamination and spoilage

Ferritinophagy and ferroptosis in cerebral ischemia reperfusion injury